Earnings Forecasts for Upcoming Market Reports on Feb 6, 2025

Market Alert: Companies releasing earnings on Feb 6, 2025, show varied forecasts. Eli Lilly, Linde, and AstraZeneca report significant EPS increases, though others like ConocoPhillips and Honeywell show declines. Investors should prepare for potential stock price impacts based on these earnings announcements.

Date: 06-02-2025

AI Rating: 7

Earnings Per Share (EPS)

The report details EPS forecasts for several companies reporting earnings. Eli Lilly and Company (LLY) is expected to report an EPS of $5.10, reflecting a substantial 104.82% year-over-year increase. On the other hand, ConocoPhillips (COP) is projected to see a decrease of 21.25%, indicating potential negative sentiment around the company's performance.

Linde plc (LIN) is also showing promise with an expected EPS of $3.93, representing a 9.47% increase. Similarly, Astrazeneca PLC (AZN) anticipates an EPS of $1.07, up 46.58%. These forecasts position LLY, LIN, and AZN positively compared to their previous earnings.

Rating Assignments

For LLY, given its high expected growth, the rating could be a strong 8. For LIN and AZN, with growth forecasts of 9.47% and 46.58% respectively, strong ratings of 7 could apply. Conversely, COP, indicating a decline of 21.25% in EPS forecasts, would receive a rating of 4. Honeywell International Inc. (HON) also shows a decrease in EPS of 11.15% and would similarly be rated a 4.

Industry Comparisons

The report highlights that LLY, LIN, and PM are expected to outperform their industry peers based on the Price to Earnings (P/E) ratios provided. By contrast, COP and HON may face challenges with lower P/E ratios compared to their industry averages.

Stocks: LLY LIN AZN PM HON COP BMY ICE TRI APD BDX HLT